Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2007-07-31
Original market date: See footnote 1
1998-02-11
Product name:
ATRACURIUM BESYLATE INJECTION
DIN:
02229757 Electronic product monograph is not available
Company:
ABBOTT LABORATORIES, LIMITED
8401 Trans-Canada Highway
Saint-Laurent
Quebec
Canada
H4S 1Z1
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
12:20.20
Anatomical Therapeutic Chemical (ATC): See footnote 4
M03AC04 ATRACURIUM
Active ingredient group (AIG) number:See footnote5
0116898001
Active ingredient(s) | Strength |
---|---|
ATRACURIUM BESYLATE | 10 MG / ML |